NCT06723899 Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast Cancer
| NCT ID | NCT06723899 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Dublin, Trinity College |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 248 participants |
| Start Date | 2024-11-13 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 248 participants in total. It began in 2024-11-13 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Women with breast cancer make up a significant proportion of cancer survivors, with more than 43,750 women living with breast cancer in Ireland. However, many women report physical and psychological health difficulties that interfere with their ability to return to work. In Ireland, and internationally, these difficulties are being increasingly recognised, with recent research identifying gaps in rehabilitation services to prepare women with breast cancer to return to work. Collaborating with women with breast cancer, and those who provide health and supportive services to individuals living with cancer in Ireland, an online self-management intervention, CanWork, was developed. CanWork aims to support women with breast cancer to manage the process of returning to work and learn strategies to manage post-treatment health-related difficulties. CanWork also provides information on workplace entitlements. This intervention was trialled with women with breast cancer in 2021, who reported that the programme gave them confidence to return to work and that the content was relevant. This study will include a larger group of women with breast cancer to determine if CanWork is effective in supporting return to work. To do this, 248 women with breast cancer will be included in the study, half of whom will receive CanWork and the results will be compared with women who do not receive the intervention. Having a programme that is financially viable is important and therefore the costs involved in running and attending the intervention will also be calculated. Should this study demonstrate that CanWork is effective in supporting women with breast cancer to return to work, the study team will collaborate with cancer services in Ireland to make the programme available nationally.
Eligibility Criteria
Inclusion Criteria: * Women with confirmed diagnosis of breast cancer * Women with breast cancer who were in paid employment prior to their cancer diagnosis * Women with breast cancer who have completed adjuvant oncology treatment (excluding hormone therapy, targeted and biological therapies) within the last 12 months * Women with breast cancer who have capacity to participate in a six-week online occupational therapy intervention Exclusion Criteria: * Women with metastatic breast cancer * Women with breast cancer who were not in paid employment prior to their cancer diagnosis * Women with breast cancer who have decided not to return to work following completion of cancer treatment * Women with breast cancer who have co-morbidity that would interfere with capacity to participate in a six-week online occupational therapy intervention
Contact & Investigator
Deirdre Connolly, PhD
PRINCIPAL INVESTIGATOR
University of Dublin, Trinity College
Frequently Asked Questions
Who can join the NCT06723899 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 70 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06723899 currently recruiting?
Yes, NCT06723899 is actively recruiting participants. Contact the research team at connoldm@tcd.ie for enrollment information.
Where is the NCT06723899 trial being conducted?
This trial is being conducted at Galway, Ireland, Waterford, Ireland.
Who is sponsoring the NCT06723899 clinical trial?
NCT06723899 is sponsored by University of Dublin, Trinity College. The principal investigator is Deirdre Connolly, PhD at University of Dublin, Trinity College. The trial plans to enroll 248 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.